HIV Infections — Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant
Citation(s)
The Efficacy, Safety, and Tolerability of Switching to a Bictegravir (BIC)/Emtricitabine(FTC)/Tenofovir Alafenamide (TAF) Regimen in Virally Suppressed HIV-Positive Patients Post-Renal Transplant